Next Article in Journal
Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre, Open-Label, Randomised Trial (INu-RC)
Previous Article in Journal
The Socio-Cultural Factors Influencing the Level of Public Compliance with Infection Control Measures during the 1918 Influenza Pandemic in Italy: A Historical Approach
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 12
Issue 6
10.3390/healthcare12060695
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Understanding the Impact of Chronic Non-Cancer Pain on Daily Life from a Gender Perspective Using the PAIN_Integral Scale©

by
Rocío Cáceres-Matos
1,
Soledad Vázquez-Santiago
1,*,
Manuel Pabón-Carrasco
1,*,
Andrés Cabrera-León
2,3 and
Eugenia Gil-García
1
1
Research Group CTS-1050: “Complex Care, Chronicity and Health Outcomes”, Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009 Seville, Spain
2
Department of Public Health, Andalusian School of Public Health, 18011 Granada, Spain
3
Biomedical Research Consortium in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Healthcare 2024, 12(6), 695; https://doi.org/10.3390/healthcare12060695
Submission received: 7 November 2023 / Revised: 9 February 2024 / Accepted: 16 March 2024 / Published: 20 March 2024
(This article belongs to the Section Women's Health Care)
Review Reports Versions Notes

Abstract

:
The experience of chronic non-cancer pain differs between women and men due to gender-related factors. This study (1) assessed the difference in responses to the impact of chronic non-cancer pain on daily life in women and men using the PAIN_Integral Scale© and (2) evaluated its invariance through multigroup confirmatory factor analysis. This was conducted by means of an analysis of invariance through a multigroup confirmatory factor analysis. A cross-sectional sample of 400 participants over 18 years of age with Chronic Non-Oncological Pain in Pain Units and Primary Care Centres belonging to the Spanish Public Health System was recruited (January to March 2020). An analysis was performed to assess whether any of the items in the instrument showed different behaviours. All analyses were performed using AMOS® v.26 software. The results showed that the structure of the PAIN_Integral© Scale remained adequate when analysing its invariance in women and men, showing no metric, scalar and/or strict invariance. Therefore, these results indicated that the PAIN_Integral Scale© instrument has a different interpretation for women and men, identifying eight items with a singular functioning in both sexes and belonging to the subscales of proactivity, resilience and support network. These findings can be explained by gender stereotypes, since the dimensions where there are differences have an important social burden.

1. Introduction

Chronic Pain (CP) is considered a type of pain that persists continuously or intermittently for more than three months [1], and when not associated with a neoplastic condition, it is denoted as Chronic Non-Cancer Pain (CNCP) [2]. Epidemiological studies calculate the prevalence of CP among 20% of the world population [3].
Consensus exists that a correct biopsychosocial assessment centred on the person improves the intensity of CNCP [4] but fundamentally it impacts daily life [4,5]. Similarly, assessment is crucial for determining the most suitable intervention or treatment and forms the basis upon which the efficacy of its methodology hinges [6].
In this sense, numerous investigations have studied the impact of CNCP on daily life. They established that CNCP influences aspects such as sleep quality [7] and limitations on daily functioning [8], but also, psychological factors such as anxiety, depression [9], self-esteem [10], pain coping [11] and resilience [8]. In addition, the experience of CNCP is uneven in different societies given the connotations that it has in each culture [12,13] and social aspects [14], as well as by sex and gender [15].
According to sex, studies suggest that women and men exhibit distinct pain responses, which appear to be attributed to genetic, anatomical, physiological, hormonal and neural factors [16].
Regarding gender, disparities may arise from the different roles and behaviours expected of men and women; that is, gender stereotypes result from the interaction of sex with differential gender socialisations in the experience of CNCP throughout life [17]. In this regard, gender stereotypes also contribute to variations in exposure to healthcare outcomes and treatments, making it an aspect that should be considered in clinical practice [18,19].
Over the years, numerous instruments have been developed and validated to assess the different areas on which CNCP has an impact. However, the use of these instruments remains a challenge and the data indicate that only 10% of healthcare professionals use them [20,21]. The low use by healthcare professionals can be justified by the large number of instruments to assess each of the aspects affected by CNCP, the variability of the methodologies and the lack of knowledge healthcare professionals have about them [22,23]. Considering these reasons, the PAIN_Integral Scale© instrument was designed and preliminarily validated in response to the need to combine all the biological, psychological and sociocultural aspects that are altered by CNCP in a single instrument, speeding up the assessment process [24,25].
Similarly, there are precedents where differences between women and men were evidenced in scales validated in the CNCP population and which are widely known and used in clinical practice, such as the Pain Catastrophising Pain Scale [26] or the McGill Short Form Pain Questionnaire [27]. Therefore, in order to verify whether there are differences in the meaning of the items in the PAIN_Integral Scale© instrument between women and men, a Multigroup Confirmatory Factor Analysis (MGCFA) of invariance has been carried out.
MGCFA technique aims to compare groups and determine whether a construct has the same meaning for different groups or samples due to its idiosyncrasies and characteristics. Thus, an invariant model ensures individuals of different groups are interpreting the items of the questionnaire and their meanings similarly, regardless of group membership (e.g., sex: women and men). This confirms that scores from the instrument truly correspond with the underlying constructs and are not due to group-specific attributions [28]. The objectives of this study were to test the structure of the PAIN_Integral Scale© using MGCFA to assess its invariance in women and men and to analyse the items that show a differential functioning between both groups.

2. Materials and Methods

2.1. Design

The study comprised a cross-sectional multicentre design following the recommendations from the guide Sex and Gender Equity in Research (SAGER), which was designed to guide authors in the communication of research results for sex–gender [29]. The STROBE checklist was also adhered to (see Table S1).

2.2. Study Setting and Sampling

The sample size was designed following the recommendations of McCallum [30] and the COSMIN Checklist Statement [31], which estimates a minimum of five and seven individuals per item, respectively, which means a range from 180 to 252 participants. The minimum sample size to be used was also calculated using G*Power V.3.1.9.4 for a large effective size (f2 = 0.35), a power of 0.90 and a statistical significance of 95% (α = 0.05) [32,33,34]. The minimum number of subjects was considered to be 386, but the sample size of our study was larger with a total of 400 subjects.

2.3. Inclusion and Exclusion Criteria

Inclusion criteria were being over 18 years of age and suffering from any CNCP condition. Exclusion criteria covered patients who suffered from cancer pain, neurodegenerative diseases, cognitive impairment or difficulties with oral communication in the Spanish language.

2.4. Instrument with Validity and Reliability

The impact of CNCP on daily life was assessed using the PAIN_Integral Scale©. This instrument facilitates the consolidation of various areas affected by CNCP into a unified scale, expediting the assessment process and considering aspects not addressed by other instruments. The PAIN_Integral Scale© is an instrument composed of 36 items with a Type-Likert scale from one to five points available in the Spanish language. The results of its validation study showed adequate reliability (α = 0.72) and a structure of nine dimensions that explained 68.22% of the variance. The nine dimensions are self-care, mobility, sleep, treatment compliance, proactivity, resilience, support network, hopelessness due to pain and pain catastrophising. The results of the Confirmatory Factor Analysis (CFA) demonstrated a good fit for the proposed 9-subscale model Goodness of Fit Index (GFI = 0.93), the Standardised Root Mean Residual (SRMR = 0.05), and the Root Mean Square Error of Approximation (RMSEA = 0.06). Scores on the scale range from 36 to 180 points and are divided into three intervals (36–130: Severe impact; 131–135: Moderate impact; 136–180: Mild impact) [24,25].

2.5. Data Collection

Data from participants were collected between January and March 2020 at Pain Units and Primary Healthcare Centres belonging to the Spanish Public Health System (Virgen del Rocio University Hospital; Virgen Macarena University Hospital; Virgen de Valme University Hospital and San Juan de Dios Aljarafe Hospital) in the province of Seville, in southern Spain. A trained researcher asked all participants every question so there were no missing items. The participants’ responses were entered in a Google form to create the database. Data on sociodemographic and clinical variables were collected, as presented in Table 1.

2.6. Data Analysis

Descriptive statistics were performed to summarise the characteristics of the sample. Continuous variables were expressed by means ( x ¯ ) with the corresponding confidence intervals (CIs), and categorical variables were expressed as percentages (%) and CIs. The comparison of the different groups’ proportions was assessed using the Chi-Square test (χ2 test) for categorical variables and Student’s T-Test for continuous variables. Significance was considered to be 5% in all descriptive analyses using version 2.7.2 of the free software R© (the R project, Auckland, New Zealand).
Invariant analysis was performed by MGCFA and was conducted using an unconstrained–constrained approach. First, an unconstrained model was run, which allowed parameters to vary freely. The unconstrained model, also known as a configural model, means that the factors have identical items in both groups and serve as a baseline which subsequent models are tested against. This analysis was followed by a fully constrained model, where parameters were constrained to be equivalent across groups (sex: women/men), assessing metric and scalar invariance. Metric invariance assesses whether the factor loadings are equal across groups; nevertheless, metric invariance ensures that the meaning of the common factors is similar across groups. Scalar invariance ensures that the intercepts of the items are equal in the different groups, which means that they are not contaminated or influenced by external factors (group-specific attributes). Scalar invariance implies that the means of the latent variables are comparable across groups [35,36].
The structural invariance assumption is supported if MGCFA meets the following criteria [37]:
(1)
The model specifying the items measuring each latent variable fits the data well. Several fit indices were considered to test the CFA structure of the model: RMSEA < 0.08 [38,39]; Comparative Fit Index (CFI > 0.90) [39,40]; χ2 test (a non-significant χ2 test (p-value > 0.05) indicates an acceptable model structure); and the relationship between χ2 and the degrees of freedom (df) (χ2/df < 3) [38,41].
(2)
All factor loadings are substantial (above 0.30) and statistically significant.
(3)
No large modification indices exist that point to model miss-specifications. Model fit was compared using χ2 difference test (χ2diff), given the change in degrees of freedom between models with a cut-off of 0.01 [35,36,42]. Differences in CFI (ΔCFI) and RMSEA (ΔRMSEA) lower than 0.01 and 0.015, respectively, were also required between unconstrained and constrained models.
Structural analyses were performed using the Analysis of Moment Structures (AMOS©) version 26 software (IBM Corp., Armonk, NY, USA).
To assess whether any of the items on the scale show a different relationship in the construct measured by the groups, the Item Differential Functioning (IDF) was evaluated. The Rasch method was used if the following assumptions were met: (1) scale invariance; (2) homogeneity of the items; and (3) local independence in the responses of the items. If these assumptions were not met, the χ2 test was used to examine the distribution of responses between the groups [43,44]. In this last case, the effective size was evaluated using the contingency coefficient Phi (Φ), considering a small effective size (Φ ≤ 30), medium (30 < Φ ≤ 50) and large (Φ > 50). These analyses were carried out using the Statistical Package for the Social Sciences (SPSS©) version 26 software (IBM Corp., Armonk, NY, USA).

2.7. Ethical Considerations

The research committee of the Virgen Macarena-Virgen del Rocio University Hospital approved this study with the code 1373-N-20. All patients who met the inclusion criteria were informed about the study and invited to participate by providing written or verbal informed consent. Regarding this last one, since the study did not involve a modification of the treatment, progression or course of the disease, and it is an observational study, it could be considered a low risk for the participating individuals. The Research Ethics Committee approved this option of verbal consent, as outlined in the study protocol. Likewise, similar to those who provided written verbal consent, participants were given the participant information sheet, and all aspects related to the study were explained to them. Participants responded affirmatively and clearly expressed their interest in being part of the study.

3. Results

3.1. Characteristics of the Sample

This study’s subjects comprised a total of 252 women (63%) and 148 men (37%). Table 1 shows data on age, PAIN_Integral Scale© score, centre, marital status and employment situation, among others disaggregated by sex (Table 2).

3.2. Evaluation of the Invariance of the Measurement Model

Results from the MGCFA and χ2diff test indicated that moderation on sex was present at the model level, which means that there were differences in the structure of the instrument between women and men. Firstly, the unconstrained model of the nine-solution model for women and men was assessed. Fit indices showed that the fit of the model data was adequate (CFI = 0.913; RMSEA = 0.038, 95% CI (0.034–0.041); χ2/df = 1.56) to compare the invariance with the metric and scalar models (Table 3). In addition, all standardised factor loadings for this nine-factor model were from 0.49 to 0.96 in women and men (Table 4).
Table 3 shows the comparison of the fit indicators between the different calculated invariance models. Firstly, the metric invariance model was tested, in which the factor loadings were restricted to be equal between men and women. The indices showed that the model fitted well, but when compared with the unconstrained model, χ2diff was significant (p < 0.001). However, the ΔRMSEA was less than 0.015 and ΔCFI was lower than 0.01. These results mean the model does not show metric invariance (Table 3).
The test of the scalar invariance model, in which the intercepts, in addition to the factor loadings, were restricted to be equal between the groups (by sex), showed a good fit. When compared with the metric invariance model, significant changes were observed in χ2diff (p < 0.001), while conversely, no significant changes were observed in the RMSEA (ΔRMSEA < 0.015) or in the CFI (ΔCFI < 0.01). These results mean the model does not show scalar invariance.
Finally, in the strict invariance model, in which the error variances were restricted, in addition to factor loadings and intercepts, the structure showed a good fit. However, once it was compared with the scalar invariance model, significant changes were observed in χ2diff (p < 0.001). Conversely, no significant changes were observed in the RMSEA (ΔRMSEA < 0.015) or the CFI (ΔCFI < 0.01). These results mean the model does not show strict invariance.
On the one hand, these results indicate that the structure of the instrument remained adequate when analysed separately for men and women. On the other hand, the overall understanding of the theoretical concept of the impact of CNCP on daily life is different for both sexes due to the characteristics of each group.

3.3. Evaluation of the Differential Functioning of the Item

The Item Differential Functioning was assessed using the χ2 test, since the data did not meet the assumptions for the Rasch method. Eight items were identified as items with different functions between women and men (items 16, 20, 23, 26, 27, 28, 29 and 30) (Table 5). These items belong to the subscales of proactivity, resilience and social support.

4. Discussion

The scientific literature recognises that there are differences in the experience of CNCP in women and men and that these are complex due to the cultural and social construction of gender [45]. Therefore, it is necessary to assess whether there are differences in the understanding of the items between both groups. The objectives of this study were to test the structure of the PAIN_Integral Scale© using MGCFA to assess its invariance in women and men and to analyse the items that show different functions between both of them.
The results are based on the fact that the fit indices of the original nine-factor, 36-item PAIN_Integral Scale© met the criteria for goodness of fit. Although previous studies did not find differences between women and men in the mean scores of the complete scale [24,25], when the invariance of the instrument was verified from the comparison of the metric (p < 0.001), scalar (p < 0.001) and strict invariance (p < 0.001) models, differences were identified between women and men.
However, the good fit indices of each model when the elements of the factorial structure remain invariant based on sex, except for one of the parameters of each model, means that partial invariance can be assumed [46] since strict invariance tests are excessively restrictive [47]. This also seems to indicate that the non-invariance between women and men is not due to an inadequate fit to the measurement or structural model.
Therefore, the main results of this study show that differences in responses between men and women were detected, which may reflect differences in the interpretation of the questions or alternatively, differences in the impact of pain. The discernment of differences appears to be manifested in eight items of the PAIN_Integral Scale©, and consequently, in the constructs to which these items belong. On the other, these differences may be explained by gender reasons. Since there is no exact definition of the concept of the impact of the CNCP on daily life or other scales that measure this theoretical construct, it is not possible to compare the existence or non-existence of invariance in other instruments [24]. However, differences between women and men have also been found in scales validated in the population with CNCP and that are widely known and used in clinical practice, such as the Pain Catastrophising Scale [26] or the Short-Form McGill Pain Questionnaire [27].
With respect to the items, IDF analysis has shown that the non-invariance could be explained by eight items (item 16, item 20, item 23 and items 26 to 30). These items belong to proactivity, resilience and support network subscales. Item 16 “I try to know more about my pain so I can cope” belongs to the proactivity subscale and showed worse scores in women than in men. Proactivity is defined as “the processes which are employed to detect and prevent probable goal threats while working towards personal goals” [48].
In this sense, studies indicate that coping strategies in women and men are based on psychosocial aspects and are influenced by gendered expectations [49,50] and societal beliefs about how women and men are expected to behave [51]. While men use more distractive and problem-focused behaviours, women use a wider range of coping strategies, such as more emotionally focused strategies and social supports, which are often ineffective [11,46]. In line with the results for this item, a study carried out by Ouwehand et al. (2008) found that men used more proactive coping strategies than women [52].
Item 20 “I think I’m a strong person” belongs to the resilience construct and showed higher scores in women than in men. The conception of strength is determined and characterised by the social and cultural context, as well as by gender socialisation learned throughout life, known as a mechanical metaphor for pain. This means that the female body has been credited with the ability to withstand extreme pain throughout their lives [53]. The same occurs in dysmenorrhea, where women do not seek health care since they have normalised the pain [54]. In a qualitative study carried out by Chen et al. (2018), the participating women accepted dysmenorrhea as “something normal” or “something to live with” [55] (Chen et al., 2018). Therefore, this experience of constant pain throughout life is integrated into other painful experiences, such as CNCP [56].
On the other hand, while women are educated during childhood to verbalise discomfort and recognise the presence of the disease [18,51], for men, the Traditional Hegemonic Model of Masculinity (THMM) has determined a representation of masculine stoicism in the face of expressing physical and emotional discomfort that questions masculinity in its absence [53]. The male ideal based on this THMM positions men to be in control and fear vulnerability, strength and self-sufficiency [57], which is associated with worse health outcomes and resistance to seeking health care, among other aspects [57,58]. This produces a greater frequentation of health services by women, mistakenly understood as a greater morbidity instead of a greater predisposition to consult [59,60].
The remaining six items (item 23 “Do you have someone you can count on when you need to talk”; item 26—“Do you have someone to inform you and help you understand the situation”; item 27—“Do you have someone to do things with you to forget your problems”; item 28—“Do you have someone to help you with your households chores if you are sick”; item 29—“Do you have anyone to have fun with”; and item 30—“Do you have someone who understands your problems”) belong to the social support construct. Considering that a support network is defined as “information leading the subject to believe that he or she is cared for and loved, esteemed, and a member of a network of mutual obligation” [61,62], this concept has been related to a positive adaptation to pain [63].
All of these six items showed higher scores in men and these results are not consistent with those found in other studies related to support networks. According to Samulowitz et al. (2022), men showed lower emotional social support (OR = 0.54 (95 CI 0.39–0.74) [64]. Conversely, social and emotional skills have traditionally been associated with women in the Traditional Hegemonic Femininity Model, while the capacity for decision-making and self-confidence is related to the THMM [65,66]. Regarding the latter, men tend to have more instrumental support in the tasks and management of care and disease. However, in women, having the responsibility of domestic work, double and triple shifts and little support in care tasks and management have been associated with poorer health, especially in women who suffer from CNCP [67,68,69]. Other studies have also found that loneliness is more prevalent in women than in men and that these differences are accentuated when there is a disabling illness [70]. In fact, in other pathologies such as cardiovascular disease, it was found that in women, loneliness increased their suffering by 13% [71].

4.1. Strength and Limitations of the Work

As strengths, the results of this study have direct implications for clinical practice, from an economic and health perspective. CNCP generates significant costs for healthcare systems. The PAIN_Integral Scale© instrument makes it possible to identify the level of impact of CNCP at an early stage, favouring the approach and reducing the health cost, considering the differences between women and men. Regarding methodological aspects, a sample size much larger than the minimum required was used. In addition, the analysis of invariance using MGCFA has recently been included in the COSMIN Checklist Statement, which also justifies the need to carry out these analyses in psychometric validation studies [31].
As limitations, despite the differences found, we must take into account certain variables that can modify the response, mainly marital status and age. Marital status may be related to the participants’ support network. In addition, age is intimately related to the generational experiences where the individual develops and, therefore, this may influence gender roles. On the other hand, racial, ethnic and cultural differences have not been considered. In this regard, only a binary conception of the sex–gender system has been taken into account, not contemplating other identities or non-normative realities. On the other hand, the limitations derived from the study design itself (cross-sectional descriptive study), as well as the self-report data, must be taken into account.

4.2. Recommendations for Further Research

In future lines of research, racial, ethnic and cultural differences should be considered, besides contemplating other identities or non-normative realities. Therefore, since both the CNCP and gender differences are mediated by the aforementioned aspects, it would be necessary to replicate the study in the future, evaluating the understanding of the items from this intersectional perspective. An example of this is the analysis of invariance in widely known instruments such as the Pain Catastrophising Scale in Native American and Non-Hispanic White Adults [72] and the Pain Assessment in Advanced Dementia (PAINAD) between White and Black people [73]. Finally, much like the differences in item comprehension have been evaluated, it would be interesting, in future studies, to analyse the similarities found between women and men, making this another perspective line to consider.

4.3. Implications for Policy and Practice

Gender inequalities across the world cause damage and this justifies comprehensive action in health at all levels [74]. According to Westergaard et al. (2019), women are diagnosed later than men in more than 700 diseases, including CNCP [75], in addition to there being a lack of care centred on women [76]. A traditional example of this is the management of cardiovascular diseases since they were identified in the 1930s [77,78,79]. According to authors such as Vlassof and García-Montero (2002), gender is key to understanding all dimensions of healthcare, and consequently, a transformation to integrate gender perspective is necessary [80]. Other authors highlight the need to develop practical tools that facilitate the application of interventions taking gender into account, allowing the treatment to be adapted to women who have traditionally been treated with treatments made for men [81].
Integrating sex and gender analysis into the design of research and as categories or variables is also important to avoid bias in the research [82]. This is supported by a whole series of recommendations and regulations at an international level, such as those of the European Commission (2019) [82] or the United States National Institutes of Health [83,84], as well as the Millennium Development Goals and Sustainable Development Goals of the United Nations [85].
Regarding the impact on clinical practices, in a study carried out by Stockbridge et al. (2015) in the United States, authors found that health spending per person increased by 4000 USD per person when the CNCP did not cause disability. This figure rose to more than 13,000 USD when the level of interference was severe [86]. The PAIN_Integral Scale© instrument makes it possible to identify the level of impact of CNCP at an early stage, favouring the approach and reducing the health cost, considering the differences between women and men. The use of a single instrument that allows for joint assessment of all impacted areas would facilitate its use by health professionals and would serve as a support in their therapeutic plans.

5. Conclusions

The structure of the PAIN_Integral Scale© has remained adequate when analysed in women and men. The results have shown the existence of partial invariance in the structure of the PAIN_Integral Scale© instrument for assessing CNCP in daily life between women and men. This fact could explain the differences in the understanding of the eight items due to the particular idiosyncrasies of both groups, where gender stereotypes learned through differential gender socialisation seem to play an important role. Integrating sex and gender analysis into the study of CNCP is necessary to adapt the treatment to women, who have traditionally been treated with treatments made for men.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare12060695/s1, Table S1: Strobe Statement.

Author Contributions

Conceptualization, R.C.-M. and E.G.-G.; methodology, R.C.-M., A.C.-L. and M.P.-C.; analysis, R.C.-M., M.P.-C. and A.C.-L.; investigation, R.C.-M.; data curation, R.C.-M. and A.C.-L.; writing—original draft preparation, R.C.-M.; writing—review and editing, M.P.-C. and E.G.-G.; supervision, E.G.-G. and S.V.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was approved on January 2020 by the Institutional Review Board (IRB) at the research committee of the Virgen Macarena-Virgen del Rocio University Hospital (approval No. 1373-N-20).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data may be obtained from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Raja, S.N.; Carr, D.B.; Cohen, M.; Finnerup, N.B.; Flor, H.; Gibson, S.; Keefe, F.J.; Mogil, J.S.; Ringkamp, M.; Sluka, K.A.; et al. The revised International Association for the Study of Pain definition of pain: Concepts, challenges, and compromises. Pain 2020, 161, 1976–1982. [Google Scholar] [CrossRef]
  2. Cunha, C.O.; Pinto-Fiamengui, L.M.S.; Sampaio, F.A.; Conti, P.C.R. Is aerobic exercise useful to manage chronic pain? Rev. Dor 2016, 17, 61–64. [Google Scholar] [CrossRef]
  3. El-Metwally, A.; Shaikh, Q.; Aldiab, A.; Al-Zahrani, J.; Al-Ghamdi, S.; Alrasheed, A.A.; Househ, M.; Da’ar, O.B.; Nooruddin, S.; Razzak, H.A.; et al. The prevalence of chronic pain and its associated factors among Saudi Al-Kharj population; a cross sectional study. BMC Musculoskelet. Disord. 2019, 20, 177. [Google Scholar] [CrossRef]
  4. Ministerio de Sanidad, Servicios Sociales e Igualdad. Framework Document for Improving the Approach to Pain in the National Health System 2014. Available online: https://www.sanidad.gob.es/areas/calidadAsistencial/estrategias/abordajeCronicidad/docs/CISNS_DocumentoMarcoDolor.pdf (accessed on 10 September 2023).
  5. Sánchez-Jiménez, J.; Tejedor-Varillas, A.; Carrascal-Garrido, R.; García-García, C.R.; Gómez-García, S.; González Sánchez, M.; Javier Gallo Vallejo, F.; Carlos Hermosa Hernán, J.; Vargas Negrín, F.; Nieto-Pol, E. Care Patients Chronic Non-Cancer Pain (CNCP) Prim. Care (PC). Documento de Consenso. 2015. Available online: https://www.agamfec.com/wp/wp-content/uploads/2015/06/Documento-de-Consenso_La-atencio%CC%81n-al-paciente-con-DCNO-en-AP.pdf (accessed on 10 September 2023).
  6. Martínez-Olivares, M.V.; Cegueda-Benítez, B.E.; Romero-Quechol, G.; Galarza-Palacios, M.E.; Rosales-Torres, M.G. Work competence of the Nurse in the assessment by functional health patterns. Rev. Enfermería Inst. Mex. Seguro Soc. 2015, 23, 3–8. Available online: https://www.medigraphic.com/pdfs/enfermeriaimss/eim-2015/eim151b.pdf (accessed on 8 September 2023).
  7. Mun, C.J.; Thummala, K.; Davis, M.C.; Karoly, P.; Tennen, H.; Zautra, A.J. Predictors and social consequences of daily pain expectancy among adults with chronic pain. Pain 2017, 158, 1224–1233. [Google Scholar] [CrossRef]
  8. Kawai, K.; Kawai, A.T.; Wollan, P.; Yawn, B.P. Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study. Fam. Pract. 2017, 34, 656–661. [Google Scholar] [CrossRef]
  9. Campbell, G.; Darke, S.; Bruno, R.; Degenhardt, L. The prevalence and correlates of chronic pain and suicidality in a nationally representative sample. Aust. N. Z. J. Psychiatry 2015, 49, 803–811. [Google Scholar] [CrossRef] [PubMed]
  10. Orhurhu, V.J.; Pittelkow, T.P.; Hooten, W.M. Prevalence of smoking in adults with chronic pain. Tob. Induc. Dis. 2015, 13, 17. [Google Scholar] [CrossRef] [PubMed]
  11. El-Shormilisy, N.; Strong, J.; Meredith, P.J. Associations between gender, coping patterns and functioning for individuals with chronic pain: A systematic review. Pain Res. Manag. 2015, 20, 48–55. [Google Scholar] [CrossRef] [PubMed]
  12. Shoiab, M.; Sherlock, R.; Ali, R.B.; Suleman, A.; Arshad, M. A language specific and culturally adapted pain management programme. Physiother. J. 2016, 102, e197–e198. [Google Scholar] [CrossRef]
  13. Torres-Cueco, R. Pain culture health-care system in the postmodern society. J. Physiother. Pain Assoc. 2018, 2018, 5–9. [Google Scholar]
  14. Cheung, C.W.; Choi, S.W.; Wong, S.; Lee, Y.; Irwin, M.G. Changes in Prevalence, Outcomes, and Help-seeking Behavior of Chronic Pain in an Aging Population Over the Last Decade. Pain Pract. 2017, 17, 643–654. [Google Scholar] [CrossRef]
  15. Jonsdottir, T.; Aspelund, T.; Jonsdottir, H.; Gunnarsdottir, S. The relationship between chronic pain pattern, interference with life and health-related quality of life in a nationwide community sample. Pain Manag. Nurs. 2014, 15, 641–651. [Google Scholar] [CrossRef]
  16. Pieretti, S.; Giannuario, A.D.; Giovannandrea, R.D.; Marzoli, F.; Piccaro, G.; Minosi, P.; Aloisi, A.M. Gender differences in pain and its relief. Ann. Dell’istituto Super. Sanita 2016, 52, 184–189. [Google Scholar]
  17. Mogil, J.S. Qualitative sex differences in pain processing: Emerging evidence of a biased literature. Nat. Rev. Neurosci. 2020, 21, 353–365. [Google Scholar] [CrossRef] [PubMed]
  18. del Mar García-Calvente, M.; Hidalgo-Ruzzante, N.; Del Río-Lozano, M.; Marcos-Marcos, J.; Martínez-Morante, E.; Maroto-Navarro, G.; Mateo-Rodríguez, I.; Gil-García, E. Exhausted women, tough men: A qualitative study on gender differences in health, vulnerability and coping with illness in Spain. Sociol. Health Illn. 2012, 34, 911–926. [Google Scholar] [CrossRef] [PubMed]
  19. Melander, S. Different logics of pain: The gendered dimension of chronic pain in a relational setting. Soc. Sci. Med. 2023, 335, 116229. [Google Scholar] [CrossRef]
  20. Breivik, H.; Borchgrevink, P.C.; Allen, S.M.; Rosseland, L.A.; Romundstad, L.; Hals, E.K.B.; Kvarstein, G.; Stubhaug, A. Assessment of pain. Br. J. Anaesth. 2008, 101, 17–24. [Google Scholar] [CrossRef]
  21. Breivik, H.; Collett, B.; Ventafridda, V.; Cohen, R.; Gallacher, D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur. J. Pain 2006, 10, 287–333. [Google Scholar] [CrossRef]
  22. Ferrer-Peña, R.; Gil-Martínez, A.; Pardo-Montero, J.; Jiménez-Penick, V.; Gallego-Izquierdo, T.; La Touche, R. Adaptation and validation of the Spanish version of the Graded Chronic Pain Scale. Reumatol. Clin. 2016, 12, 130–138. [Google Scholar] [CrossRef]
  23. Registered Nurses’ Association of Ontario. Pain Assessment and Management. 2013. Available online: https://rnao.ca/sites/rnao-ca/files/2015_-_BPG_Pain_16_01_2015_-_3rd_Edition.pdf (accessed on 11 October 2023).
  24. Cáceres-Matos, R.; Gil-García, E.; Rivera-Sequeiros, A.; López-Millán, J.M. Design and preliminarily validation of a tool to assess the impact of chronic non-cancer pain on people’s daily life in Spanish-language: PAIN_Integral Scale©. J. Adv. Nurs. 2021, 77, 3553–3570. [Google Scholar] [CrossRef] [PubMed]
  25. Cáceres-Matos, R.; Gil-García, E.; Vázquez-Santiago, S.; Cabrera-León, A. Factors that influence the impact of Chronic Non-Cancer Pain on daily life: A partial least squares modelling approach. Int. J. Nurs. Stud. 2023, 138, 104383. [Google Scholar] [CrossRef]
  26. D’Eon, J.L.; Harris, C.A.; Ellis, J.A. Testing Factorial Validity and Gender Invariance of the Pain Catastrophizing Scale. J. Behav. Med. 2004, 27, 361–372. [Google Scholar] [CrossRef] [PubMed]
  27. Sandhu, S.S. Validating the factor structure and testing measurement invariance of modified Short-Form McGill Pain Questionnaire (Ortho-SF-MPQ) for orthodontic pain assessment. J. Orthod. 2017, 44, 34–43. [Google Scholar] [CrossRef] [PubMed]
  28. Casanova, M.P.; Nelson, M.C.; Pickering, M.A.; Appleby, K.M.; Grindley, E.J.; Larkins, L.W.; Baker, R.T. Measuring psychological pain: Psychometric analysis of the Orbach and Mikulincer Mental Pain Scale. Meas. Instrum. Soc. Sci. 2021, 3, 7. [Google Scholar] [CrossRef]
  29. Heidari, S.; Babor, T.F.; De Castro, P.; Tort, S.; Curno, M. Sex and gender equity in research: Rationale for the SAGER guidelines and recommended use. Gac. Sanit. 2019, 33, 203–210. [Google Scholar] [CrossRef] [PubMed]
  30. McCallum, A. What is an outcome and why look at them? Crit. Public Health 1993, 4, 4–10. [Google Scholar] [CrossRef]
  31. Mokkink, L.B.; de Vet, H.C.W.; Prinsen, C.A.C.; Patrick, D.L.; Alonso, J.; Bouter, L.M.; Terwee, C.B. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual. Life Res. 2018, 27, 1171–1179. [Google Scholar] [CrossRef]
  32. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Erlbowm: Hillsdale, NJ, USA, 1988. [Google Scholar]
  33. Faul, F.; Erdfelder, E.; Lang, A.G.; Buchner, A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [Google Scholar] [CrossRef]
  34. Green, B.G. How many subjects does it take to do a regression analysis? Multivar. Behav. Res. 1991, 26, 499–510. [Google Scholar] [CrossRef]
  35. Brown, T.A. Confirmatory Factor Analysis for Applied Research, 2nd ed.; Guilford Publications: New York, NY, USA, 2014. [Google Scholar]
  36. Byrne, B. Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming, 3rd ed.; Routledge: London, UK, 2016. [Google Scholar] [CrossRef]
  37. Cheung, G.W.; Rensvold, R.B. Evaluating Goodness-of-Fit Indexes for Testing Measurement Invariance. Struct. Equ. Model. A Multidiscip. J. 2002, 9, 233–255. [Google Scholar] [CrossRef]
  38. Browne, M.W.; Cudeck, R. Alternative ways of assessing model fit. Sociol. Methods Res. 1992, 21, 230–258. [Google Scholar] [CrossRef]
  39. Hu, L.; Bentler, P.M. Cutoff criteria for fit indices in covariance structure analysis: Conventional criteria versus new alternatives. Struct. Equ. Model. 1999, 6, 1–55. [Google Scholar] [CrossRef]
  40. Bentler, P.M. Comparative fit indexes in structural models. Psychol. Bull. 1990, 107, 238–246. [Google Scholar] [CrossRef] [PubMed]
  41. West, S.G.; Taylor, A.B.; Wei, W. Model fit and model selection in structural equation modeling. In Handbook of Structural Equation Modeling; Hoyle, R.H., Ed.; Guilford Press: New York, NY, USA, 2012; pp. 209–231. [Google Scholar]
  42. Gaskin, J. Chi Square Difference Testing. Gaskination’s StatWiki. 2012. Available online: http://statwiki.kolobkreations.com (accessed on 29 September 2023).
  43. Bond, T.G.; Fox, C.M. Applying the Rasch Model: Fundamental Measurement in the Human Sciences, 3rd ed.; Routledge: London, UK, 2015. [Google Scholar]
  44. González-Betanzos, F.; Rivera-Heredia, M.E.; Padrós-Blázquez, F. Sex Invariance on the Generalized Anxiety Disorder Screening Scale (EDTAG). Actual. En Psicol. 2015, 29, 141. [Google Scholar] [CrossRef]
  45. Bimpong, K.; Thomson, K.; Mcnamara, C.L.; Balaj, M.; Akhter, N.; Bambra, C.; Todd, A. The Gender Pain Gap: Gender inequalities in pain across 19 European countries. Scand. J. Public Health 2022, 50, 287–294. [Google Scholar] [CrossRef] [PubMed]
  46. Dimitrov, D.M. Testing for Factorial Invariance in the Context of Construct Validation. Meas. Eval. Couns. Dev. 2010, 43, 121–149. [Google Scholar] [CrossRef]
  47. Bentler, P.M. EQS 6 Structural Equations Program Manual; Multivariate Software: Encino, CA, USA, 2005; Available online: www.mvsoft.com (accessed on 27 September 2023).
  48. Aspinwall, L.G. Where planning meets coping: Proactive coping and the detection and management of potential stressors. In The Developmental Psychology Of Planning: Why, How, and When Do We Plan? Friedman, S.L., Scholnick, E.K., Eds.; Lawrence Erlbaum Associates: London, UK, 1997; pp. 285–320. [Google Scholar]
  49. Bartley, E.J.; Fillingim, R.B. Sex differences in pain: A brief review of clinical and experimental findings. Br. J. Anaesth. 2013, 111, 52–58. [Google Scholar] [CrossRef] [PubMed]
  50. Keogh, E. The gender context of pain. Health Psychol. Rev. 2021, 15, 454–481. [Google Scholar] [CrossRef] [PubMed]
  51. Samulowitz, A.; Gremyr, I.; Eriksson, E.; Hensing, G. “Brave Men” and “Emotional Women”: A Theory-Guided Literature Review on Gender Bias in Health Care and Gendered Norms towards Patients with Chronic Pain. Pain Res. Manag. 2018, 6358624. [Google Scholar] [CrossRef]
  52. Ouwehand, C.; De Ridder, D.T.D.; Bensing, J.M. Individual differences in the use of proactive coping strategies by middle-aged and older adults. Personal. Individ. Differ. 2008, 45, 28–33. [Google Scholar] [CrossRef]
  53. Wood, W.; Bourke, J. Conceptualising Gender and Pain in Modern History. Gend. Hist. 2020, 32, 8–12. [Google Scholar] [CrossRef]
  54. Chen, C.X.; Kwekkeboom, K.L.; Ward, S.E. Beliefs About Dysmenorrhea and Their Relationship to Self-Management. Res. Nurs. Health 2016, 39, 263–276. [Google Scholar] [CrossRef]
  55. Chen, C.X.; Shieh, C.; Draucker, C.B.; Carpenter, J.S. Reasons women do not seek health care for dysmenorrhea. J. Clin. Nurs. 2018, 27, e301–e308. [Google Scholar] [CrossRef]
  56. Jaworska, S.; Ryan, K. Gender and the language of pain in chronic and terminal illness: A corpus-based discourse analysis of patients’ narratives. Soc. Sci. Med. 2018, 215, 107–114. [Google Scholar] [CrossRef]
  57. Blackbeard, D.; Aldous, C. Chronic pain and masculine identity: Life-world interviews with men at a South African Pain Clinic. Int. J. Qual. Stud. Health Well-Being 2021, 16, 1970303. [Google Scholar] [CrossRef]
  58. Fleming, P.J.; Agnew-Brune, C. Current trends in the study of gender norms and health behviors. Curr. Opin. Psychol. 2015, 5, 72–77. [Google Scholar] [CrossRef]
  59. Markez, I.; Póo, M.; Romo, N.; Meneses, C.; Gil, E.; Vega, A. Mujeres y psicofármacos: La investigación en atención primaria. Rev. Asoc. Española Neuropsiquiatría 2004, 91, 37–61. Available online: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-57352004000300004 (accessed on 10 September 2023). [CrossRef]
  60. Romo, N.; Meneses, C. Discomforts in women and differential uses of psychotropic drugs: Critical proposals from feminism. In Adicciones: Conocimiento, Atención Integrada y Acción Preventiva; Asociación Española de Neuropsiquiatría: Madrid, Spain, 2015; pp. 113–126. Available online: https://www.ugr.es/ (accessed on 11 September 2023).
  61. Cobb, S. Presidential Address-1976. Social support as a moderator of life stress. Psychosom. Med. 1976, 38, 300–314. [Google Scholar] [CrossRef]
  62. Fernández-Peña, R.; Molina, J.L.; Valero, O. Personal Network Analysis in the Study of Social Support: The Case of Chronic Pain. Int. J. Environ. Res. Public Health 2018, 15, 2695. [Google Scholar] [CrossRef]
  63. Ibrahim, N.; Teo, S.S.; Che Din, N.; Abdul Gafor, A.H.; Ismail, R. The Role of Personality and Social Support in Health-Related Quality of Life in Chronic Kidney Disease Patients. PLoS ONE 2015, 10, e0129015. [Google Scholar] [CrossRef]
  64. Samulowitz, A.; Hensing, G.; Haukenes, I.; Bergman, S.; Grimby-Ekman, A. General self-efficacy and social support in men and women with pain–irregular sex patterns of cross-sectional and longitudinal associations in a general population sample. BMC Musculoskelet. Disord. 2022, 23, 1026. [Google Scholar] [CrossRef]
  65. Campbell, K.A.; Ford-Gilboe, M.; Kennedy, K.; Jackson, K.; Mantler, T.; Oudshoorn, A. Women’s experiences of navigating chronic pain within the context of living with an episodic disability. Women’s Health 2022, 18, 174550572211039. [Google Scholar] [CrossRef]
  66. Gazerani, P.; Aloisi, A.M.; Ueda, H. Editorial: Differences in Pain Biology, Perception, and Coping Strategies: Towards Sex and Gender Specific Treatments. Front. Neurosci. 2021, 15, 697285. [Google Scholar] [CrossRef]
  67. Angelov, N.; Johansson, P.; Lindahl, E. Gender Differences in Sickness Absence and the Gender Division of Family Responsibilities. Institute for Evaluation of Labour Market and Education Policy (IFAU). 2013, pp. 1–54. Available online: https://www.ifau.se/globalassets/pdf/se/2013/wp2013-09-gender-differences-in-sickness-absence-and-the-gender-division-of-family-responsibilities.pdf (accessed on 9 September 2023).
  68. Arman, M.; Gebhardt, A.; Hök Nordberg, J.; Andermo, S. Women’s Lived Experiences of Chronic Pain: Faces of Gendered Suffering. Qual. Health Res. 2020, 30, 772–782. [Google Scholar] [CrossRef]
  69. Harryson, L.; Novo, M.; Hammarstrom, A. Is gender inequality in the domestic sphere associated with psychological distress among women and men? Results from the Northern Swedish Cohort. J. Epidemiol. Community Health 2012, 66, 271–276. [Google Scholar] [CrossRef]
  70. Pagan, R. Gender and Age Differences in Loneliness: Evidence for People without and with Disabilities. Int. J. Environ. Res. Public Health 2020, 17, 9176. [Google Scholar] [CrossRef]
  71. Golaszewski, N.M.; LaCroix, A.Z.; Godino, J.G.; Allison, M.A.; Manson, J.E.; King, J.J.; Weitlauf, J.C.; Bea, J.W.; Garcia, L.; Kroenke, C.H.; et al. Evaluation of Social Isolation, Loneliness, and Cardiovascular Disease Among Older Women in the US. JAMA Netw. Open 2022, 5, e2146461. [Google Scholar] [CrossRef]
  72. Rhudy, J.L.; Arnau, R.C.; Huber, F.A.; Lannon, E.W.; Kuhn, B.L.; Palit, S.; Payne, M.F.; Sturycz, C.A.; Hellman, N.; Guereca, Y.M.; et al. Examining Configural, Metric, and Scalar Invariance of the Pain Catastrophizing Scale in Native American and Non-Hispanic White Adults in the Oklahoma Study of Native American Pain Risk (OK-SNAP). J. Pain Res. 2020, 13, 961–969. [Google Scholar] [CrossRef] [PubMed]
  73. Resnick, B.; Van Haitsma, K.; Kolanowski, A.; Galik, E.; Boltz, M.; Ellis, J.; Behrens, L.; Eshraghi, K.; Renn, C.L.; Dorsey, S.G. Invariance of the PAINAD Scale Between the Black and White Residents Living with Dementia. Front. Pain Res. 2021, 2, 757654. [Google Scholar] [CrossRef]
  74. Sen, G.; Östlin, P.; George, A. Unequal, Unfair, Ineffective and Inefficient. Gender Inequity in Health: Why It Exists and How We Can Change It; Final Report of the Women and Gender Equity Knowledge Network (WGEKN); World Health Organization: Genève, Switzerland, 2007; Volume 1, Available online: https://eurohealth.ie/wp-content/uploads/2012/02/Unequal-Unfair-Ineffective-and-Inefficient-Gender-Inequity-in-Health.pdf (accessed on 9 September 2023).
  75. Westergaard, D.; Moseley, P.; Sørup, F.K.H.; Baldi, P.; Brunak, S. Population-wide analysis of differences in disease progression patterns in men and women. Nat. Commun. 2019, 10, 666. [Google Scholar] [CrossRef]
  76. Alcalde-Rubio, L.; Hernández-Aguado, I.; Parker, L.A.; Bueno-Vergara, E.; Chilet-Rosell, E. Gender disparities in clinical practice: Are there any solutions? Scoping review of interventions to overcome or reduce gender bias in clinical practice. Int. J. Equity Health 2020, 19, 166. [Google Scholar] [CrossRef] [PubMed]
  77. Ayanian, J.Z.; Epstein, A.M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N. Engl. J. Med. 1991, 325, 221–225. [Google Scholar] [CrossRef]
  78. Healy, B. The Yentl syndrome. N. Engl. J. Med. 1991, 325, 274–276. [Google Scholar] [CrossRef]
  79. Steingart, R.M.; Packer, M.; Hamm, P.; Coglianese, M.E.; Gersh, B.; Geltman, E.M.; Sollano, J.; Katz, S.; Moyé, L.; Basta, L.L.; et al. Sex differences in the management of coronary artery disease. Survival ad Ventricular Enlargement Investigators. N. Engl. J. Med. 1991, 325, 226–230. [Google Scholar] [CrossRef] [PubMed]
  80. Vlassoff, C.; Garcia Moreno, C. Placing gender at the centre of health programming: Challenges and limitations. Soc. Sci. Med. 2002, 54, 1713–1723. [Google Scholar] [CrossRef]
  81. Chilet-Rosell, E. Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs. Glob. Health Action 2014, 7, 25484. [Google Scholar] [CrossRef]
  82. European Commission. H2020 Expert Group to Update and Expand “Gendered Innovations/Innovation through Gender” 2019. Available online: https://european-union.europa.eu/index_en (accessed on 22 September 2023).
  83. Tannenbaum, C.; Ellis, R.P.; Eyssel, F.; Zou, J.; Schiebinger, L. Sex and gender analysis improves science and engineering. Nature 2019, 575, 137–146. [Google Scholar] [CrossRef]
  84. National Institutes of Health. National Pain Strategy Report. 2021. Available online: https://www.iprcc.nih.gov/node/5/national-pain-strategy-report (accessed on 22 September 2023).
  85. Gupta, G.R.; Oomman, N.; Grown, C.; Conn, K.; Hawkes, S.; Shawar, Y.R.; Shiffman, J.; Buse, K.; Mehra, R.; Bah, C.A.; et al. Gender Equality, Norms, and Health Steering Committee. Gender equality and gender norms: Framing the opportunities for health. Lancet 2019, 393, 2550–2562. [Google Scholar] [CrossRef]
  86. Stockbridge, E.L.; Suzuki, S.; Pagán, J.A. Chronic Pain and Health Care Spending: An Analysis of Longitudinal Data from the Medical Expenditure Panel Survey. Health Serv. Res. 2015, 50, 847–870. [Google Scholar] [CrossRef]
Table 1. Data collections.
Table 1. Data collections.
  • Age: 16–44 years old, 45–64 years old and over 65 years old.
  • Centre: Virgen del Rocio University Hospital; Virgen Macarena University Hospital; Valme University Hospital; and San Juan de Dios Aljarafe Hospital and Primary Healthcare Centres.
  • Marital status: married, unmarried, separated/divorced and widowed.
  • Employment situation: employed, unemployed, retired/medical leave, homemaker and student.
  • Level of education: early childhood education, primary school, secondary school and higher education.
  • Type of town: fewer than 10,000 inhabitants, from 10,000 to 50,000 inhabitants, more than 50,000 inhabitants and capitals.
  • Location of chronic pain: cervical spine; thoracic spine; lumbar spine; sacral bone; shoulder; armpit/side/arm; elbow; wrist/hand; hips; legs; knee; ankle/foot; stomach; abdomen; facial; migraine/headache; and fibromyalgia.
  • PAIN_Integral Scale©: severe impact, moderate impact and mild impact
Table 2. Descriptive analysis. Sociodemographic characteristics of the sample.
Table 2. Descriptive analysis. Sociodemographic characteristics of the sample.
Variables (n = 400)Women (n = 252)Men (n = 148)p-Value
Mean (SD)Mean (SD)p < 0.001 *
62.0 (14.0)56.2 (14.0)
Age% (SD)% (SD)p < 0.05 **
 16–4410.6 (3.8)17.8 (6.2)
 45–6446.7 (6.2)56.8 (24.5)
 65+42.3 (6.1)24.7 (6.9)
Mean (SD)Mean (SD)p = 0.11 *
121.47 (15.58)123.49 (14.14)
PAIN_Integral Scale©% (SD)% (SD)p = 0.82 **
 Severe impact (36–130)68.7 (5.8)67.2 (7.6)
 Moderate impact (131–135)13.3 (4.2)12.3 (5.3)
 Mild impact (136–180)18.0 (4.8)20.5 (6.5)
Centre p < 0.05 **
 Virgen del Rocio University Hospital77.5 (5.2)74.0 (1.1)
 Virgen Macarena University Hospital6.4 (1.6)11.0 (5.1)
 Virgen de Valme University Hospital3.2 (1.1)7.5 (2.2)
 San Juan de Dios Aljarafe Hospital2.4 (1.9)2.1 (2.1)
 Primary Healthcare Centres10.5 (3.8)7.4 (4.2)
Marital status p < 0.05 **
 Married55.3 (6.5)76.0 (6.1)
 Unmarried12.6 (4.1)12.3 (5.3)
 Separated/Divorced10.6 (3.8)9.6 (4.8)
 Widowed21.1 (5.1)1.4 (1.4)
Employment situation p < 0.05 **
 Employed15.4 (4.5)24.7 (6.9)
 Unemployed4.9 (2.7)6.8 (4.1)
 Retired/medical leave60.2 (6.1)66.4 (8.3)
 Homemaker18.7 (4.8)0.7 (0.7)
 Student0.8 (0.8)0.7 (0.7)
Level of education p < 0.05 **
 Early childhood education15.4 (4.5)5.5 (3.7)
 Primary school54.9 (6.2)52.7 (8.1)
 Secondary school17.1 (4.7)29.5 (11.0)
 Higher education12.6 (4.1)11.0 (5.1)
Type of town p < 0.05 **
 Fewer than 10,000 inhabitants17.7 (4.7)20.5 (6.5)
 From 10,000 to 50,000 inhabitants38.2 (6.0)38.4 (7.9)
 More than 50,000 inhabitants1.2 (1.2)1.4 (1.4)
 Capitals43.0 (6.1)39.7 (8.0)
Location of chronic non-cancer pain p < 0.05 **
 Cervical spine23.2 (5.2)16.4 (6.0)
 Thoracic spine12.6 (4.1)7.5 (4.3)
 Lumbar spine54.9 (6.2)61.6 (7.9)
 Sacral bone25.1 (5.7)26.6 (7.2)
 Shoulder18.3 (4.8)6.8 (4.1)
 Armpit/side/arm15.9 (4.5)11.0 (5.1)
 Elbow7.3 (3.2)2.7 (2.6)
 Wrist/hand17.5 (4.7)8.2 (4.4)
 Hips 15.4 (4.5)10.3 (4.9)
 Legs36.6 (6.0)43.3 (8.0)
 Knee19.5 (4.9)15.8 (5.9)
 Ankle/foot16.7 (4.6)11.0 (5.1)
 Stomach3.7 (2.3)0.0 (0.0)
 Abdomen6.1 (3.0)4.8 (3.5)
 Facial1.2 (1.2)0.7 (0.7)
 Migraine/headache10.2 (3.8)7.5 (4.3)
 Fibromyalgia27.6 (5.5)6.2 (3.9)
* Student’s T-test; ** Chi-square test; SD: Standard deviation.
Table 3. Standardised factor loadings of the PAIN_Integral Scale© by sex.
Table 3. Standardised factor loadings of the PAIN_Integral Scale© by sex.
ItemsMobility W (m)Self-Care W (m)Sleep W (m)Treatment Compliance W (m)Proactivity
W (m)		Resilience W (m)Support network W (m)Hopelessness Due to Pain W (m)Pain Catastrophising W (m)
Item 1. Over the last week, how many days have you visited your family or friends?0.57 (0.70)
Item 2. Over the last week, how many days have you gone for a walk?0.64 (0.73)
Item 3. Over the last week, how many days have you gone shopping?0.77 (0.77)
Item 4. Over the last week, how many days have you gotten dressed alone? 0.86 (0.86)
Item 5. Over the last week, how many days have you carried out personal hygiene practices alone? 0.97 (0.93)
Item 6. Over the last week, how many days have you carried out your personal grooming? 0.93 (0.91)
Item 7. In the last week, how many days have you had difficulty achieving restful sleep? 0.78 (0.79)
Item 8. In the last week, how many days have you been worried or noticed tiredness or a decrease in your socio-labour functioning due to not having slept well the night before? 0.90 (0.96)
Item 9. In the last week, how many days have you felt too drowsy, falling asleep during the day or sleeping more than usual at night? 0.62 (0.72)
Item 10. In the last week, how many days did you forget to take your medication? 0.81 (0.81)
Item 11. In the last week, how many days did you not take your medication because you felt okay? 0.50 (0.66)
Item 12. In the last week, how many days did you not take your medication because you felt bad? 0.62 (0.44)
Item 13. In the last week, how many days did you not take your medication because you didn’t want to take so many drugs? 0.62 (0.78)
Item 14. In the last week, how many days did you not take your medication because you thought it wouldn’t work? 0.60 (0.51)
Item 15. I’m trying to get them to explain what I can do to lessen the pain. 0.68 (0.70)
Item 16. I try to know more about my pain so I can cope. 0.72 (0.79)
Item 17. I’m talking to someone who can do something specific about my pain. 0.79 (0.56)
Item 18. I’m able to adapt to changes. 0.61 (0.65)
Item 19. I can overcome any challenge that is presented to me. 0.72 (0.61)
Item 20. I think I’m a strong person. 0.66 (0.66)
Item 21. I can handle unpleasant feelings. 0.57 (0.72)
Item 22. I’m proud of my accomplishments. 0.69 (0.56)
Item 23. Do you have someone you can count on when you need to talk? 0.79 (0.81)
Item 24. Do you have someone to take you to the doctor when you need it? 0.53 (0.71)
Item 25. Do you have someone to show you love and affection? 0.73 (0.80)
Item 26. Do you have someone to inform you and help you understand the situation? 0.78 (0.77)
Item 27. Do you have someone to do things with you to forget your problems? 0.90 (0.90)
Item 28. Do you have someone to help you with your household chores if you are sick? 0.52 (0.74)
Item 29. Do you have anyone to have fun with? 0.92 (0.89)
Item 30. Do you have someone who understands your problems? 0.84 (0.76)
Item 31. The pain is very strong, and I don’t think it’s ever going to get better. 0.49 (0.61)
Item 32. The pain is very unpleasant, and I feel like I’m out of it. 0.85 (0.79)
Item 33. I feel like I can’t stand the pain anymore. 0.87 (0.86)
Item 34. I feel like I don’t have the strength to fight anymore. 0.78 (0.82)
Item 35. I don’t care what could happen to me anymore. 0.88 (0.86)
Item 36. I feel I have lost my emotional stamina. 0.87 (0.85)
M: men; W: women.
Table 4. Comparison of the fit index between invariance models.
Table 4. Comparison of the fit index between invariance models.
Modelχ2χ2/(df)CFIRMSEA (95% CI)χ2diffΔCFIΔRMSEA
Unconstrained 1739.901.560.9130.038 (0.034–0.041)
Metric invariance model1802.611.580.9080.038 (0.035–0.042)62.71 (27)
p < 0.001		−0.0050.000
Scalar invariance model1862.781.580.9050.038 (0.035–0.042)60.17 (36)
p < 0.001		−0.0030.000
Strict invariance model2048.181.630.9000.040 (0.037–0.043)126.76 (36)
p < 0.001		−0.0050.002
χ2 = Chi Square test; χ2diff = χ2 difference test; CFI = Comparative Fit Index; CI = Confidence interval; RMSEA = Root-Mean-Squared error of Approximation.
Table 5. Item Differential Functioning.
Table 5. Item Differential Functioning.
Item ResponseWomen
% (SD)		Men
% (SD)		p-Value *
Item 1. Over the last week, how many days have you visited your family or friends? 0.451 a
6–7 days32.5 (5.8)37.0 (7.8)
4–5 days2.8 (2.07)4.8 (4.8)
3 days8.4 (3.5)6.8 (4.1)
1–2 days19.3 (4.9)2.9 (1.9)
No day36.9 (6.0)29.6 (7.4)
Item 2. Over the last week, how many days have you gone for a walk? 0.121 a
6–7 days44.2 (6.1)50.7 (8.1)
4–5 days2.8 (2.0)6.8 (4.1)
3 days6.0 (3.0)6.8 (4.1)
1–2 days15.7 (4.5)11.0 (5.0)
No day31.3 (5.7)24.7 (6.9)
Item 3. Over the last week, how many days have you gone shopping? 0.991 a
6–7 days81.9 (4.7)82.2 (6.2)
4–5 days1.2 (1.1)1.4 (1.4)
3 days1.6 (0.9)1.4 (1.4)
1–2 days2.0 (1.7)1.4 (1.4)
No day13.3 (4.2)13.7 (5.5)
Item 4. Over the last week, how many days have you gotten dressed alone? 0.991 a
6–7 days81.9 (4.7)82.2 (6.2)
4–5 days1.2 (1.1)1.4 (1.4)
3 days1.6 (1.1)1.4 (1.4)
1–2 days2.0 (1.7)1.4 (1.4)
No day13.3 (4.2)13.7 (5.5)
Item 5. Over the last week, how many days have you carried out personal hygiene practices alone? 0.689 a
6–7 days83.5 (4.6)83.6 (6.0)
4–5 days0.8 (0.5)2.1 (2.1)
3 days1.6 (1.1)0.7 (1.3)
1–2 days2.4 (1.9)3.4 (2.9)
No day11.6 (3.9)10.3 (4.9)
Item 6. Over the last week, how many days have you carried out your personal grooming? 0.522 a
6–7 days83.5 (4.6)88.4 (5.2)
4–5 days1.6 (1.1)0.7 (1.3)
3 days2.0 (1.7)0.7 (1.3)
1–2 days3.2 (2.2)1.4 (1.4)
No day9.6 (3.7)8.9 (4.6)
Item 7. In the last week, how many days have you had difficulty achieving restful sleep? 0.359 a
6–7 days47.4 (6.2)41.8 (7.9)
4–5 days10.4 (3.8)10.3 (4.9)
3 days10.8 (3.8)7.5 (44.2)
1–2 days6.4 (3.0)10.3 (4.9)
No day2.9 (2.1)30.1 (7.4)
Item 8. In the last week, how many days have you been worried or noticed tiredness or a decrease in your socio-labour functioning due to not having slept well the night before? 0.210 a
6–7 days44.2 (6.1)43.8 (8.0)
4–5 days9.2 (3.6)8.9 (4.6)
3 days9.2 (3.6)6.8 (4.1)
1–2 days10.0 (3.7)4.8 (2.1)
No day27.3 (5.5)35.6 (7.7)
Item 9. In the last week, how many days have you felt too drowsy, falling asleep during the day or sleeping more than usual at night? 0.652 a
6–7 days37.8 (6.0)34.2 (7.6)
4–5 days7.2 (3.2)6.2 (3.9)
3 days10.8 (3.8)8.9 (4.6)
1–2 days8.8 (4.1)7.5 (4.2)
No day35.3 (5.9)43.2 (8.0)
Item 10. In the last week, how many days did you forget to take your medication? 0.473 a
6–7 days6.4 (3.0)10.3 (4.9)
4–5 days2.8 (2.0)2.1 (2.3)
3 days1.6 (1.1)3.4 (2.9)
1–2 days8.0 (3.3)7.5 (4.2)
No day81.1 (4.8)76.7 (6.8)
Item 11. In the last week, how many days did you not take your medication because you felt okay? 0.522 a
6–7 days1.2 (1.1)2.7 (2.6)
4–5 days0.8 (0.5)0.7 (1.3)
3 days0.0 (0.0)0.7 (1.3)
1–2 days1.2 (1.1)0.7 (1.3)
No day96.8 (2.2)95.2 (3.4)
Item 12. In the last week, how many days did you not take your medication because you felt bad? 0.574 a
6–7 days2.3 (1.9)2.7 (2.6)
4–5 days0.1 (0.3)0.7 (1.3)
3 days0.0 (0.0)0.0 (0.0)
1–2 days1.2 (1.1)0.7 (1.3)
No day96.4 (2.3)95.9 (3.2)
Item 13. In the last week, how many days did you not take your medication because you didn’t want to take so many drugs? 0.352 a
6–7 days3.2 (2.2)5.5 (10.9)
4–5 days0.8 (0.5)0.7 (1.3)
3 days0.8 (0.5)0.0 (0.0)
1–2 days2.8 (2.0)0.7 (1.3)
No day92.4 (3.3)93.2 (4.1)
Item 14. In the last week, how many days did you not take your medication because you thought it wouldn’t work? 0.533 a
6–7 days2.8 (2.0)1.4 (1.9)
4–5 days0.0 (0.0)0.7 (1.3)
3 days0.4 (0.4)0.0 (0.0)
1–2 days0.8 (0.5)0.1 (0.5)
No day96.8 (2.2)97.8 (2.4)
Item 15. I’m trying to get them to explain what I can do to lessen the pain. 0.561 a
Never24.1 (5.3)18.5 (6.3)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes9.6 (3.7)11.0 (5.0)
Most of the time 11.6 (3.9)14.4 (5.7)
Always54.6 (6.1)56.2 (8.0)
Item 16. I try to know more about my pain so I can cope. 0.011 b
Never45.4 (6.1)30.8 (7.4)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes5.2 (2.7)11.6 (5.2)
Most of the time8.4 (3.5)11.0 (5.0)
Always41.0 (6.1)46.6 (8.0)
Item 17. I’m talking to someone who can do something specific about my pain. 0.338 a
Never33.3 (5.8)25.3 (7.0)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes10.8 (3.8)14.4 (5.7)
Most of the time 12.0 (4.0)11.6 (5.2)
Always43.8 (6.1)48.6 (8.1)
Item 18. I’m able to adapt to changes. 0.859 a
Never12.4 (4.1)15.1 (5.8)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes15.7 (11.2)15.8 (5.9)
Most of the time 18.1 (4.7)15.8 (5.9)
Always53.8 (6.1)53.4 (8.0)
Item 19. I can overcome any challenge that is presented to me. 0.100 a
Never14.9 (4.4)24.0 (6.9)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes21.3 (5.0)22.6 (6.7)
Most of the time 20.5 (5.0)19.2 (6.3)
Always43.4 (6.1)34.2 (7.6)
Item 20. I think I’m a strong person. 0.008 b
Never9.6 (3.7)6.8 (4.1)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes10.4 (3.8)22.6 (6.7)
Most of the time12.9 (4.1)14.4 (5.7)
Always67.1 (3.8)56.2 (8.0)
Item 21. I can handle unpleasant feelings. 0.937 a
Never16.9 (4.6)18.5 (6.3)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes24.1 (5.3)21.9 (15.2)
Most of the time 15.3 (4.4)16.4 (6.0)
Always43.8 (6.1)43.2 (8.0)
Item 22. I’m proud of my accomplishments. 0.475 a
Never8.4 (3.5)11.0 (5.0)
Rarely0.0 (0.0)0.0 (0.0)
Sometimes12.9 (4.1)15.1 (5.8)
Most of the time 11.6 (3.9)7.5 (4.2)
Always67.1 (3.8)66.4 (7.6)
Item 23. Do you have someone you can count on when you need to talk? 0.043 b
Never6.0 (2.9)4.1 (3.3)
Rarely6.8 (3.1)6.8 (4.1)
Sometimes13.7 (4.2)6.8 (4.1)
Most of the time8.4 (3.5)15.1 (5.8)
Always65.1 (5.9)67.1 (7.6)
Item 24. Do you have someone to take you to the doctor when you need it? 0.430 a
Never5.6 (3.2)6.2 (3.9)
Rarely4.0 (2.44)4.1 (0.8–7.2)
Sometimes7.2 (3.2)3.4 (2.9)
Most of the time 7.2 (3.2)11.0 (5.0)
Always75.9 (5.3)75.3 (6.9)
Item 25. Do you have someone to show you love and affection? 0.303 a
Never2.8 (2.0)1.4 (1.9)
Rarely4.4 (2.5)2.1 (2.3)
Sometimes9.6 (3.7)6.2 (3.9)
Most of the time 7.2 (3.2)10.3 (4.9)
Always75.9 (5.3)80.1 (5.4)
Item 26. Do you have someone to inform you and help you understand the situation? 0.034 b
Never10.0 (3.7)6.8 (4.1)
Rarely7.6 (3.3)8.2 (4.4)
Sometimes16.1 (4.5)6.2 (3.9)
Most of the time8.0 (3.3)8.9 (4.6)
Always58.2 (6.1)69.9 (7.4)
Item 27. Do you have someone to do things with you to forget your problems? 0.019 b
Never8.8 (4.1)8.2 (4.4)
Rarely9.6 (3.7)2.7 (2.6)
Sometimes14.9 (4.4)8.9 (4.6)
Most of the time7.6 (3.3)11.6 (5.2)
Always59.0 (6.1)68.5 (7.5)
Item 28. Do you have someone to help you with your household chores if you are sick? 0.012 b
Never12.9 (4.1)6.8 (4.1)
Rarely6.0 (2.9)2.7 (2.6)
Sometimes6.4 (3.0)2.7 (2.6)
Most of the time7.6 (3.3)4.1 (3.3)
Always67.1 (5.8)83.6 (6.0)
Item 29. Do you have anyone to have fun with? 0.041 b
Never12.0 (4.0)5.5 (10.9)
Rarely7.2 (3.2)4.8 (3.4)
Sometimes11.6 (3.9)6.8 (4.1)
Most of the time7.2 (3.2)8.9 (4.6)
Always61.8 (6.0)74.0 (7.1)
Item 30. Do you have someone who understands your problems? 0.047 b
Never8.8 (4.1)6.2 (3.9)
Rarely9.6 (3.7)4.1 (3.3)
Sometimes13.7 (4.2)11.0 (5.0)
Most of the time11.2 (3.9)8.2 (4.4)
Always56.6 (6.1)70.5 (7.3)
Item 31. The pain is very strong and I don’t think it’s ever going to get better. 0.900 a
Never10.0 (3.7)12.3 (5.3)
Rarely5.2 (2.7)5.5 (10.9)
Sometimes24.5 (5.3)22.6 (6.7)
Most of the time 16.9 (4.6)19.2 (6.3)
Always43.4 (6.1)40.4 (7.9)
Item 32. The pain is very unpleasant and I feel like I’m out of it. 0.299 a
Never8.4 (3.5)9.6 (4.7)
Rarely3.6 (2.3)6.2 (3.9)
Sometimes30.1 (6.1)32.2 (7.5)
Most of the time 22.1 (5.1)26.0 (7.1)
Always35.7 (5.9)26.0 (7.1)
Item 33. I feel like I can’t stand the pain anymore. 0.869 a
Never13.3 (4.2)15.8 (5.9)
Rarely6.8 (3.1)7.5 (4.2)
Sometimes32.5 (5.8)32.2 (7.5)
Most of the time 16.9 (4.6)18.5 (6.3)
Always30.5 (5.7)26.0 (7.1)
Item 34. I feel like I don’t have the strength to fight anymore. 0.547 a
Never17.3 (4.7)17.8 (6.2)
Rarely8.4 (3.45)6.8 (4.1)
Sometimes28.5 (5.6)35.6 (7.7)
Most of the time 30.9 (5.7)24.7 (6.9)
Always14.9 (4.4)15.1 (5.8)
Item 35. I don’t care what could happen to me anymore. 0.127 a
Never11.2 (3.9)13.0 (5.4)
Rarely27.3 (5.5)18.5 (6.3)
Sometimes19.7 (4.9)28.8 (7.3)
Most of the time 6.0 (2.9)7.5 (4.2)
Always35.7 (5.9)32.2 (7.5)
Item 36. I feel I have lost my emotional stamina. 0.306 a
Never10.0 (3.7)12.3 (5.3)
Rarely29.3 (5.6)19.9 (6.4)
Sometimes25.3 (5.4)26.0 (7.1)
Most of the time 8.8 (4.1)11.6 (5.2)
Always26.5 (5.4)30.1 (7.4)
* Chi-Square test; a Small effect size (Φ ≤ 30); b Medium effect size (30 < Φ ≤ 50); Use of bold: Questions with differential item compression.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cáceres-Matos, R.; Vázquez-Santiago, S.; Pabón-Carrasco, M.; Cabrera-León, A.; Gil-García, E. Understanding the Impact of Chronic Non-Cancer Pain on Daily Life from a Gender Perspective Using the PAIN_Integral Scale©. Healthcare 2024, 12, 695. https://doi.org/10.3390/healthcare12060695

AMA Style

Cáceres-Matos R, Vázquez-Santiago S, Pabón-Carrasco M, Cabrera-León A, Gil-García E. Understanding the Impact of Chronic Non-Cancer Pain on Daily Life from a Gender Perspective Using the PAIN_Integral Scale©. Healthcare. 2024; 12(6):695. https://doi.org/10.3390/healthcare12060695

Chicago/Turabian Style

Cáceres-Matos, Rocío, Soledad Vázquez-Santiago, Manuel Pabón-Carrasco, Andrés Cabrera-León, and Eugenia Gil-García. 2024. "Understanding the Impact of Chronic Non-Cancer Pain on Daily Life from a Gender Perspective Using the PAIN_Integral Scale©" Healthcare 12, no. 6: 695. https://doi.org/10.3390/healthcare12060695

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop